Journal article · 2017 · Open access

The content validity of the PSS in patients with plaque psoriasis

Anne M. Rentz, Anne M. Skalicky, Kate Burslem, K. Becker, Dagmar Kaschinski, D. Esser, Dennis A. Revicki

Journal of Patient-Reported Outcomes, 1(1), 4 · Published 12 September 2017 · DOI 10.1186/s41687-017-0004-7

Open PDFView at the publisherCite this paper

In brief

“The content validity of the PSS in patients with plaque psoriasis” is a 2017 journal article by Anne M. Rentz and 6 co-authors, published in Journal of Patient-Reported Outcomes. OpenAlex counts 18 citations as of 22 November 2026. It is open access under a CC BY licence: the full text is free to read at Journal of Patient-Reported Outcomes.

Citations
18
Most cited in
2020 (4)
Field-weighted impact
0.76
References
20
Authors
7

Abstract

The primary objective of this study was to evaluate the content validity of the Psoriasis Symptom Scale (PSS), with a specific focus on understanding of the content of the PRO measure by conducting one-on-one interviews with patients with moderate to severe plaque psoriasis. This was a cross-sectional, qualitative study conducted with 20 patients with plaque psoriasis who participated in in-person, one-on-one interviews. Participants were asked to describe their psoriasis symptoms, completed the PSS, and were cognitively debriefed on its content. Interviews were conducted in two separate rounds. Following Round 1, the study data were examined to determine if modifications to the PSS were required. All interviews were audio-recorded and transcribed. Sociodemographic and clinical data were collected for sample descriptive purposes. The 20 study participants had a mean age of 50.2 ± 12.0 years (range: 25.0–73.0), and 55% were female. Thirty-five percent of the sample reported their psoriasis severity as moderate or severe. The average time since diagnosis of plaque psoriasis was almost 18 years, ranging from less than one to over 38 years. The most frequently reported symptoms and signs during the concept elicitation portion of the interviews included redness ( N = 20, 100%), itching ( n = 20, 100%), pain ( n = 15, 75%), burning ( n = 13, 65%), and flaking ( n = 11, 55%). Overall, participants provided positive feedback on the PSS and felt that it was comprehensive and relevant to their experience with psoriasis. The item meaning and response options were well-understood for the majority of the items. Findings indicate that for the patient-reported symptom of redness, which is also a sign that can be reported by clinicians, redness or the perception of redness is most accurately captured by patient report. Study results did not support modifications to the instrument and no changes to the PSS were recommended. The evidence gained in this study provided support for the content validity of the PSS for use as clinical trial endpoint among patients with plaque psoriasis. This study found that the symptoms included in the PSS are important to and well-understood by patients with plaque psoriasis. The PSS is appropriate for inclusion in future studies designed to measure the effect of treatment on psoriasis-related symptoms.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Rentz, A. M., Skalicky, A. M., Burslem, K., Becker, K., Kaschinski, D., Esser, D., & Revicki, D. A. (2017). The content validity of the PSS in patients with plaque psoriasis. Journal of Patient-Reported Outcomes, 1(1), 4. https://doi.org/10.1186/s41687-017-0004-7

MLA 9

Rentz, Anne M., et al. “The content validity of the PSS in patients with plaque psoriasis.” Journal of Patient-Reported Outcomes, vol. 1, no. 1, 2017, p. 4. https://doi.org/10.1186/s41687-017-0004-7.

Chicago

Rentz, Anne M., Anne M. Skalicky, Kate Burslem, K. Becker, Dagmar Kaschinski, D. Esser, and Dennis A. Revicki. 2017. “The content validity of the PSS in patients with plaque psoriasis.” Journal of Patient-Reported Outcomes 1 (1): 4. https://doi.org/10.1186/s41687-017-0004-7.

Harvard

Rentz, A. M. et al. (2017) ‘The content validity of the PSS in patients with plaque psoriasis’, Journal of Patient-Reported Outcomes, 1(1), p. 4. doi:10.1186/s41687-017-0004-7.

IEEE

A. M. Rentz et al., “The content validity of the PSS in patients with plaque psoriasis,” Journal of Patient-Reported Outcomes, vol. 1, no. 1, p. 4, 2017, doi: 10.1186/s41687-017-0004-7.

BibTeX

@article{rentz2017content,
  title     = {{The content validity of the PSS in patients with plaque psoriasis}},
  author    = {Rentz, Anne M. and Skalicky, Anne M. and Burslem, Kate and Becker, K. and Kaschinski, Dagmar and Esser, D. and Revicki, Dennis A.},
  journal   = {Journal of Patient-Reported Outcomes},
  year      = {2017},
  volume    = {1},
  number    = {1},
  pages     = {4},
  doi       = {10.1186/s41687-017-0004-7},
  url       = {https://doi.org/10.1186/s41687-017-0004-7}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201822
201911
202044
202133
202211
202311
202433
202511
202622

Its field-weighted citation impact is 0.76: it has been cited 0.76 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis

  • plaque psoriasis
  • content validity
  • patient-reported outcomes
  • symptom assessment
  • redness
  • pruritus
  • pain
  • clinical trial endpoints

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Rentz, A. M., Skalicky, A. M., Burslem, K., Becker, K., Kaschinski, D., Esser, D., & Revicki, D. A. (2017). The content validity of the PSS in patients with plaque psoriasis. Journal of Patient-Reported Outcomes, 1(1), 4. https://doi.org/10.1186/s41687-017-0004-7

How many times has this paper been cited?

18 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journal of Patient-Reported Outcomes: sign in and open the PDF from this page.

Who wrote this paper?

Anne M. Rentz, Anne M. Skalicky, Kate Burslem, K. Becker, Dagmar Kaschinski, D. Esser, Dennis A. Revicki.

What is the DOI of this paper?

10.1186/s41687-017-0004-7, permanently at https://doi.org/10.1186/s41687-017-0004-7. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.